Article
Metabolic and immune markers for precise monitoring of COVID-19 severity and treatment
2021-09-09
Abstract excerpt
Deep understanding of the SARS-CoV-2 effects on host molecular pathways is paramount for the discovery of early biomarkers of outcome of coronavirus disease 2019 (COVID-19) and the identification of novel therapeutic targets. In that light, we generated metabolomic data from COVID-19 patient blood using high-throughput targeted nuclear magnetic resonance (NMR) spectroscopy and high-dimensional flow cytometry. We f...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 0ae7d895-158e-5b14-a8e4-271e4b6cee9d
- DOI
- 10.1101/2021.09.05.21263141
